DarioHealth Launches GLP-1 Program, With Commercial Availability Expected Fall 2026, With Revenue Contribution From Late 2026 And Ramping Through 2027
DarioHealth Corp.
Hims & Hers Health
DarioHealth Corp. DRIO | 0.00 | |
Hims & Hers Health HIMS | 0.00 |
First commercial offering from Dario's collaboration with Beluga Health adds licensed provider evaluation, prescribing and ongoing clinical oversight directly inside Dario's chronic care platform
Launch addresses a market in which employers and health plans are reducing GLP-1 coverage and members are increasingly accessing care through consumer channels
Available through three channels: Dario's direct-to-consumer shop, health plan marketplaces and employer B2B2C programs
